These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7801143)

  • 1. Granulocyte-Macrophage Colony Stimulating Factor: Current Knowledge and Perspectives of a New Growth Factor. Proceedings of a symposium. Cologne, Germany, March 1993.
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):1-63. PubMed ID: 7801143
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for the use of granulocyte-macrophage colony-stimulating factor in oncology.
    Aglietta M; Piacibello W; Pasquino P; Sanavio F; Stacchini A; Volta C; Monteverde A; Fubini L; Morelli S; Severino A
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):5-9. PubMed ID: 7801146
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendation for using granulocyte and granulocyte-macrophage growth factor during anti-cancer therapy in children].
    Balwierz W; Moryl-Bujakowska A; Balwierz A; Pawińska K
    Przegl Lek; 2006; 63(1):1-6. PubMed ID: 16892890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of leukomax (granulocyte-macrophage colony stimulating factor) in oncology and hematology].
    Gorbunova VA
    Vopr Onkol; 1995; 41(1):21-8. PubMed ID: 7667936
    [No Abstract]   [Full Text] [Related]  

  • 5. The American Society of Clinical Oncology guideline program.
    Winn RF; Smith TF
    Pharm Pract Manag Q; 1996 Apr; 16(1):31-8. PubMed ID: 10157738
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy.
    Fisher DC; Peters WP
    Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in tumor therapy (GM-CSF, G-CSF, and IL-3). Proceedings of the satellite symposium to the 15th UICC Congress. Hamburg, Federal Republic of Germany, August 18, 1990.
    Am J Clin Oncol; 1991; 14 Suppl 1():S1-63. PubMed ID: 1710873
    [No Abstract]   [Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor (GM-CSF) in the management of cancer.
    Fan D; O'Brian CA; Ioannides CG; Clyne RK
    In Vivo; 1991; 5(6):571-7. PubMed ID: 1810441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony stimulating factor (GM-CSF) in malignancy.
    Ozsoylu S
    Pediatr Hematol Oncol; 1998; 15(5):471, 473. PubMed ID: 9783319
    [No Abstract]   [Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(1):28-35. PubMed ID: 1375975
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose intensification of chemotherapy in solid tumours with the use of recombinant human granulocyte-macrophage colony stimulating factor.
    Steward WP; Dunlop DJ; Cassidy J
    Behring Inst Mitt; 1991 Dec; (90):44-9. PubMed ID: 1801690
    [No Abstract]   [Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
    Golden EB; Chhabra A; Chachoua A; Adams S; Donach M; Fenton-Kerimian M; Friedman K; Ponzo F; Babb JS; Goldberg J; Demaria S; Formenti SC
    Lancet Oncol; 2015 Jul; 16(7):795-803. PubMed ID: 26095785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. The Health Services Research Committee of the American Society of Clinical Oncology.
    Bennett CL; Smith TJ; Weeks JC; Bredt AB; Feinglass J; Fetting JH; Hillner BE; Somerfield MR; Winn RJ
    J Clin Oncol; 1996 Sep; 14(9):2511-20. PubMed ID: 8823330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth factor frenzy.
    Quesenberry PJ
    Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic colony-stimulating factors and dose intensity.
    Petros WP; Peters WP
    Semin Oncol; 1993 Feb; 20(1):94-9. PubMed ID: 7682727
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study of granulocyte-macrophage colony-stimulating factor and interleukin-2 as immune adjuvants for a melanoma peptide vaccine.
    Block MS; Suman VJ; Nevala WK; Kottschade LA; Creagan ET; Kaur JS; Quevedo JF; McWilliams RR; Markovic SN
    Melanoma Res; 2011 Oct; 21(5):438-45. PubMed ID: 21697748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.